Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Grupo Español de Investigación en Cáncer de Ovario
National Institutes of Health Clinical Center (CC)
ARCAGY/ GINECO GROUP
Leiden University Medical Center
Baylor Research Institute
Oncology Institute of Southern Switzerland
Massachusetts General Hospital
Guardant Health, Inc.
Azienda USL Reggio Emilia - IRCCS
Lyell Immunopharma, Inc.
Imperial College Healthcare NHS Trust